RPID (Rapid Micro Biosystems) Total Liabilities: $41.97 Mil (As of Mar. 2026)

What is Rapid Micro Biosystems Total Liabilities?

Rapid Micro Biosystems RPID -1.16% 60 Total Liabilities is $41.97 Mil as of Mar. 2026. GuruFocus rates RPID with a GF Score™ of 60/100 and a GF Value™ of $1.88 (Fairly Valued). The stock has 4 warning signs investors should review.

Rapid Micro Biosystems's Total Liabilities for the quarter that ended in Mar. 2026 was $41.97 Mil.

Rapid Micro Biosystems's quarterly Total Liabilities increased from Sep. 2025 ($40.08 Mil) to Dec. 2025 ($41.65 Mil) and increased from Dec. 2025 ($41.65 Mil) to Mar. 2026 ($41.97 Mil).

Rapid Micro Biosystems's annual Total Liabilities declined from Dec. 2023 ($25.46 Mil) to Dec. 2024 ($22.82 Mil) but then increased from Dec. 2024 ($22.82 Mil) to Dec. 2025 ($41.65 Mil).

Rapid Micro Biosystems Total Liabilities Related Terms

Rapid Micro Biosystems Total Liabilities Historical Data

* Premium members only.

The historical data trend for Rapid Micro Biosystems's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Micro Biosystems Total Liabilities Chart

Rapid Micro Biosystems Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Liabilities

Get a 7-Day Free Trial

20.19

26.48

25.46

22.82

41.65

Rapid Micro Biosystems Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Liabilities	Get a 7-Day Free Trial															19.94	21.04	40.08	41.65	41.97

60GF Score

Rapid Micro Biosystems Inc RPID

Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Rapid Micro Biosystems Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Rapid Micro Biosystems's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	18.487	+	(22.576	+	0.583
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	41.65

Total Liabilities	=	Total Assets (A: Dec. 2025 )	-	Total Equity (A: Dec. 2025 )
	=	74.852	-	33.206
	=	41.65

Rapid Micro Biosystems's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	19.119	+	(22.39	+	0.456
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	41.97

Total Liabilities	=	Total Assets (Q: Mar. 2026 )	-	Total Equity (Q: Mar. 2026 )
	=	62.363	-	20.398
	=	41.97

Frequently Asked Questions Learn more about Total Liabilities →

What does a Total Liabilities of $41.97 Mil mean?

Rapid Micro Biosystems (RPID) has a Total Liabilities of $41.97 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Rapid Micro Biosystems and its competitors.

Is Rapid Micro Biosystems' Total Liabilities too high?

Rapid Micro Biosystems' current Total Liabilities is $41.97 Mil. Overall, Rapid Micro Biosystems has a GF Score™ of 60/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Rapid Micro Biosystems' Total Liabilities compare to OM and NNOX?

Rapid Micro Biosystems' Total Liabilities of $41.97 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Liabilities for a Medical Devices & Instruments company?

A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Liabilities mean?

A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Rapid Micro Biosystems and its competitors. Rapid Micro Biosystems's current Total Liabilities is $41.97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Rapid Micro Biosystems stock overvalued right now?

Based on GuruFocus' analysis, Rapid Micro Biosystems (RPID) is currently considered Fairly Valued. The stock's GF Value™ is $1.88, compared to a current price of $1.71 — trading 9% below its estimated fair value. The current Total Liabilities is $41.97 Mil. Rapid Micro Biosystems' overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Liabilities calculated?

Total Liabilities is calculated from a company's financial statements. For Rapid Micro Biosystems (RPID), the current Total Liabilities is $41.97 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rapid Micro Biosystems (RPID) Overvalued in 2026?

Based on GuruFocus' analysis, Rapid Micro Biosystems stock appears to be undervalued. The current stock price of $1.71 is trading 9% below its estimated GF Value™ of $1.88. GuruFocus considers Rapid Micro Biosystems to be Fairly Valued.

Key valuation signals for RPID:

Total Liabilities: $41.97 Mil
GF Value™: $1.88 vs. price of $1.71 (9% below fair value)
GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the RPID stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rapid Micro Biosystems Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OM NNOX STIM ZOMDF RTGN SNWV LNSR SERA ECOR POSC ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Address 25 Hartwell Avenue, Lexington, MA, USA, 02421

Website https://www.rapidmicrobio.com

Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.

60GF Score

Get the complete analysis for RPID

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.71

Price

$1.88

GF Value

View RPID Analysis

See Total Liabilities data for all stocks →